IQVIA Holdings Inc.
279.36USD
+1.0400 (+0.37%)
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on IQV.
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $3.28▲ | $3.25 | 2 | 0 |
| Next quarter | $3.65▲ | $3.62 | 0 | 2 |
| Current year | $12.96▲ | $12.8 | 1 | 2 |
| Next year | $14.39▲ | $14.17 | 1 | 5 |
Beat in 4 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | $3.03 | $3.15 | +0.12 (+3.9%) |
| 2026-03-31 | $2.82 | $2.9 | +0.08 (+3.0%) |
| 2025-12-31 | $3.4 | $3.42 | +0.02 (+0.7%) |
| 2025-09-30 | $2.98 | $3 | +0.02 (+0.8%) |
257 ratings from 35 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| Stifel | Maintained | Buy | $276 $303 | Oct 14, 2026 |
| Mizuho | Maintained | Outperform | $275 $300 | Oct 7, 2026 |
| Barclays | Maintained | Overweight | $275 $300 | Oct 7, 2026 |
| RBC Capital | Maintained | Outperform | $247 $319 | Sep 29, 2026 |
| Truist Securities | Reiterated | Buy | $300 $329 | Sep 28, 2026 |
| Morgan Stanley | Maintained | Equal-Weight | $240 $270 | Sep 17, 2026 |
| JP Morgan | Maintained | Overweight | $225 $285 | Jul 29, 2026 |
| Stifel | Maintained | Buy | $220 $276 | Jul 29, 2026 |
| TD Cowen | Maintained | Buy | $233 $288 | Jul 29, 2026 |
| RBC Capital | Maintained | Outperform | $221 $247 | Jul 29, 2026 |
| BMO Capital | Maintained | Outperform | $210 $270 | Jul 29, 2026 |
| Baird | Maintained | Outperform | $252 $287 | Jul 29, 2026 |
| Mizuho | Maintained | Outperform | $215 $230 | Jul 13, 2026 |
| Baird | Maintained | Outperform | $230 $249 | Jul 1, 2026 |
| Morgan Stanley | Downgraded from Overweight | Equal-Weight | $225 $200 | Jun 17, 2026 |
| Evercore ISI Group | Maintained | Outperform | $225 $185 | Apr 8, 2026 |
| TD Cowen | Upgraded from Hold | Buy | $174 $213 | Mar 9, 2026 |
| Barclays | Upgraded from Equal-Weight | Overweight | $210 | Mar 6, 2026 |
| RBC Capital | Initiated | Outperform | $221 | Mar 3, 2026 |
| Truist Securities | Maintained | Buy | $290 $245 | Feb 19, 2026 |
| JP Morgan | Maintained | Overweight | $255 $225 | Feb 6, 2026 |
| Citigroup | Maintained | Neutral | $230 $200 | Feb 6, 2026 |
| UBS | Maintained | Buy | $280 $240 | Feb 6, 2026 |
| Jefferies | Maintained | Buy | $270 $255 | Feb 6, 2026 |
| Stifel | Maintained | Buy | $273 $220 | Feb 6, 2026 |
45 filings from 15 insiders · 6 buy / 6 sell over 6m
Officers and directors of IQV, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Berkshire James G.Officer, See Remarks | ExerciseStock Appreciation Right | 5.4k | $131.82 | $709k | Sep 2, 2026 |
| Berkshire James G.Officer, See Remarks | Other | 2.7k | $261.54 | $710k | Sep 2, 2026 |
| Berkshire James G.Officer, See Remarks | Sell | 2.7k | $261.33 | $697k | Sep 2, 2026 |
| Berkshire James G.Officer, See Remarks | Exercise | 5.4k | $131.82 | $709k | Sep 2, 2026 |
| STAUB WALTER. RICHARD IIIOfficer | Sell | 5.5k | $232.68 | $1.28M | Aug 3, 2026 |
| PATEL BHAVIKOfficer | Sell | 1.9k | $235.27 | $436k | Jul 31, 2026 |
| BOUSBIB ARI BChief Executive Officer | Exercise | 156.2k | $78.21 | $12.22M | Jul 29, 2026 |
| CHEROFSKY KERIANNOfficer | Sell | 558 | $245.21 | $137k | Jul 29, 2026 |
| SHERBET ERIC MGeneral Counsel | Sell | 5.0k | $249.16 | $1.25M | Jul 29, 2026 |
| BOUSBIB ARI BChief Executive Officer | Sell | 106.3k | $244.78 | $26.09M | Jul 29, 2026 |
| DANHAKL JOHN GDirector | Grantindirect | 1.6k | — | — | Apr 23, 2026 |
| BURT CAROL JDirector | Grantindirect | 1.6k | — | — | Apr 23, 2026 |
| GOGGINS COLLEEN ADirector | Grant | 1.6k | — | — | Apr 23, 2026 |
| LEONARD JOHN MDirector | Grant | 1.6k | — | — | Apr 23, 2026 |
| CHEROFSKY KERIANNOfficer | Grant | 1.1k | — | — | Feb 6, 2026 |
| PATEL BHAVIKOfficer | Grant | 4.1k | — | — | Feb 6, 2026 |
| BERKSHIRE JAMES GRANTOfficer | Grant | 2.7k | — | — | Feb 6, 2026 |
| HAAS BERNDOfficer | Grant | 8.3k | — | — | Feb 6, 2026 |
| FEDOCK MICHAEL J.Officer | Grant | 6.7k | — | — | Feb 6, 2026 |
| GRENFELL ALISTAIROfficer | Grant | 11.8k | — | — | Feb 6, 2026 |
No analyst notes on IQV yet.
Analyst Ratings
18 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 3 | 16 | 2 | 0 | 0 | Buy1.95 |
| 1 mo ago | 3 | 16 | 3 | 0 | 0 | Buy2.00 |
| 2 mo ago | 3 | 15 | 3 | 0 | 0 | Buy2.00 |
| 3 mo ago | 4 | 15 | 2 | 0 | 0 | Buy1.90 |
Members whose judged calls on IQV have played out most reliably.
No settled calls on IQV yet. Nobody has filed a call with a deadline on it.
A member is listed once they have three judged calls on a name.
A call with a target is judged on whether the price reaches it by the deadline, counting each day's high (a buy) or low (a sell) from the day after the call was made. A call without one is judged on whether the price at the close on the deadline is higher (a buy) or lower (a sell) than the price the call was made at: the live price when it was saved, for a call made with Make a call, or the last close before the day it was filed, for a call made in a note. Not against the market or an index.
A percentage appears once five calls have reached their deadline. A target reached sooner is shown as played out early, and counts toward the percentage when its deadline passes, because a miss cannot be known before then.
A member’s prediction, judged on price history · not investment advice